Literature DB >> 6120713

Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

A N Nicholson, B M Stone.   

Abstract

1 Effects of the antihistamines, terfenadine (60 mg) and astemizole (10 and 20 mg), on performance (visuo-motor coordination, arithmetical ability and digit symbol substitution) and on mood were studied in six healthy adult females. The study was double-blind, placebo controlled and included an antihistamine with known central effects (triprolidine 10 mg in sustained release form). 2 There were no changes in performance after terfenadine (60 mg) and astemizole (10 and 20 mg). Triprolidine (10 mg) caused a decrement in visuo-motor coordination (P less than 0.01) 0.5 h after ingestion which lasted until 3.5 h (P less than 0.001). The subject assessed their performance as impaired from 1.5-3.5 h (P less than 0.05) with triprolidine (10 mg), and their mood assessments were also altered. 3 Terfenadine (60 mg) and astemizole (10 and 20 mg) are likely to prove useful antihistamines for those involved in skilled activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120713      PMCID: PMC1402008          DOI: 10.1111/j.1365-2125.1982.tb01356.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Performance studies with antihistamines.

Authors:  C H Clarke; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

2.  Inhibitory activity of terfenadine on histamine-induced skin wheals in man.

Authors:  K J Hüther; G Renftle; N Barraud; J T Burke; J Koch-Weser
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

3.  Chronopharmacological study of antihistamines in man with special references to terfenadine.

Authors:  A Reinberg; F Levi; P Guillet; J T Burke; A Nicolai
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

4.  Some clinical pharmacological studies with terfenadine, a new antihistamine drug.

Authors:  V K Kulshrestha; P P Gupta; P Turner; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

5.  Inhibition of histamine-N-methylation by some antihistamines.

Authors:  K J Netter; K Bodenschatz
Journal:  Biochem Pharmacol       Date:  1967-08       Impact factor: 5.858

6.  Are antihistamines sedative via a blockade of brain H1 receptors?

Authors:  A Uzan; G Le Fur; C Malgouris
Journal:  J Pharm Pharmacol       Date:  1979-10       Impact factor: 3.765

7.  A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness.

Authors:  A W Peck; A S Fowle; C Bye
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

8.  CNS effects of the antihistamines diphenhydramine and terfenadine (RMI 9918).

Authors:  M Fink; P Irwin
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1979-01

9.  Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings.

Authors:  L Moser; K J Hüther; J Koch-Weser; P V Lundt
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

10.  Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

View more
  47 in total

1.  Pharmacology of nasal medications: an update.

Authors:  G F Martin
Journal:  Can Fam Physician       Date:  1988-12       Impact factor: 3.275

2.  Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.

Authors:  J Vincent; D J Sumner; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

3.  The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.

Authors:  J Vincent; R Liminana; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

4.  The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers.

Authors:  J S Kerr; C Dunmore; I Hindmarch
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Peripheral antihistamine and central sedative effects of three H1-receptor antagonists.

Authors:  S Levander; O Hägermark; M Ståhle
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 6.  Effects of antihistamine medications on exercise performance. Implications for sportspeople.

Authors:  L C Montgomery; P A Deuster
Journal:  Sports Med       Date:  1993-03       Impact factor: 11.136

7.  Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light.

Authors:  A N Nicholson; P A Smith; M B Spencer
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

Review 8.  Effects of terfenadine on psychomotor performance. An overview.

Authors:  D W Aaronson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

9.  Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.

Authors:  K A Brookhuis; G De Vries; D De Waard
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

10.  The H2-antagonists, cimetidine and ranitidine: studies on performance.

Authors:  A N Nicholson; B M Stone
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.